Access cutting-edge cardiomyopathy treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access cardiomyopathy specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cardiomyopathy treatment provided free
To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM.
Sponsor: Intellia Therapeutics
Check if you qualify for this cardiomyopathy clinical trial in Washington Dc, DC
If you're searching for cardiomyopathy treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.